Event details
Date
Time
Duration
Available On-Demand
During the COVID-19 pandemic, circulation of respiratory viruses changed dramatically, and recent flu seasons showed atypical patterns compared to pre-pandemic times. It is expected that upcoming seasons will return to normal with the co-circulation of SARS-CoV-2, influenza, and respiratory syncytial viruses.
Accurate testing for respiratory viruses is critical for managing hospitalized patients. Moreover, the surveillance of these viruses is key for global public health.
This webinar will discuss the important characteristics of laboratory tests for the detection of viruses for patient management.
Two experts in molecular biology will present a new flexible solution for the comprehensive testing of the most life-threatening seasonal viruses including SARS-CoV-2.
Key learning objectives
- Learn about the relevance of respiratory virus testing
- Understand the importance of highly sensitive and inclusive assays for testing hospitalized patients with respiratory symptoms
- Discover a new flexible solution for clinical laboratories enabling the management of seasonal respiratory viruses
Who should attend?
Laboratory Directors, Laboratory Managers, Public health managers, Researchers, Epidemiologists, Virologists, MDs, Pulmonologists, Regulatory Specialists
Presenter
Dr. Emeline Goretti, PhD
Clinical Affairs Team Leader
Fast Track Diagnostics, Siemens Healthineers
View BioDr. Goretti is a molecular biologist with an expertise in translational research applied to human health. She received her PhD from the University of Lorraine in Nancy, France where she characterized the role of circulating microRNA as a biomarker of cardiovascular diseases. She started as an R&D scientist at Fast Track Diagnostics, a Siemens Healthineers company, and then moved to the clinical affairs department. She is currently leading a team of clinical affairs professionals and has managed several clinical studies of RT-PCR assays, detecting respiratory viruses and SARS-CoV-2 in particular.
Dr. Marta Podgórska, PhD
Research and Development Team Leader
Fast Track Diagnostics, Siemens Healthineers
View BioA biotechnologist by training, Dr. Podgórska received her PhD from the Saarland University, Homburg, Germany. She has more than 8 years of academic experience with inflammatory responses in skin and cervical cancers infected with human papillomavirus infection. She also has 4 years of industry experience in the development of quantitative and qualitative real-time PCR assays. She is currently leading a team of scientists and technicians at Fast Track Diagnostics, a Siemens Healthineers company. Her team recently developed a new multiplex RT PCR assay for the detection of respiratory viruses.
Ellen studied biological sciences at the University of the West of England, UK, before completing a master's in epidemiology from the University of Bristol. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.